Chronic growth hormone excess is associated with increased aldosterone: A study in patients with acromegaly and in growth hormone transgenic mice

Experimental Biology and Medicine

Volumn 234, Issue 8, 2009, Pages 1002-1009

  Bielohuby, Maximilian ^a   Roemmler, Josefine ^a   Manolopoulou, Jenny ^a   Johnsen, Inga ^a   Sawitzky, Mandy ^b   Schopohl, Jochen ^a   Reincke, Martin ^a   Wolf, Eckhard ^c   Hoeflich, Andreas ^b   Bidlingmaier, Martin ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b LEIBNIZ INSTITUTE FOR FARM ANIMAL BIOLOGY FBN   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

Author keywords

Acromegaly; Adrenal gland; Aldosterone; Growth hormone; IGF I; Renin

Indexed keywords

ALDOSTERONE; GROWTH HORMONE; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN C;

ACROMEGALY; ADRENAL GLAND; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; HORMONE DETERMINATION; HORMONE RELEASE; HUMAN; MAJOR CLINICAL STUDY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ACROMEGALY; ADRENAL GLANDS; ALDOSTERONE; ALDOSTERONE SYNTHASE; ANIMALS; CATTLE; FEMALE; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MICE; MICE, TRANSGENIC; MIDDLE AGED; ORGAN SIZE;

MUS; MUS MUSCULUS;

EID: 68149134828     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.3181/0901-RM-34     Document Type: Article

References (45)

1. Palmiter RD, Norstedt G, Gelinas RE, Hammer RE, Brinster RL. Metallothionein-human GH fusion genes stimulate growth of mice. Science 222:809-814, 1983.
2. Lichanska AM, Waters MJ. How growth hormone controls growth, obesity and sexual dimorphism. Trends Genet 24:41-47, 2008.
3. Lupu F, Terwilliger JD, Lee K, Segre GV, Efstratiadis A. Roles of growth hormone and insulin-like growth factor 1 in mouse postnatal growth. Dev Biol 229:141-162, 2001.
4. Davidson MB. Effect of growth hormone on carbohydrate and lipid metabolism. Endocr Rev 8:115-131, 1987.
5. Butler AA, Le Roith D. Control of growth by the somatropic axis: Growth hormone and the insulin-like growth factors have related and independent roles. Annu Rev Physiol 63:141-164, 2001.
6. Weber MM, Fottner C, Schmidt P, Brodowski KM, Gittner K, Lahm H, Engelhardt D, Wolf E. Postnatal overexpression of insulin-like growth factor II in transgenic mice is associated with adrenocortical hyperplasia and enhanced steroidogenesis. Endocrinology 140:1537-1543, 1999.
7. Hoeflich A, Weber MM, Fisch T, Nedbal S, Fottner C, Elmlinger MW, Wanke R, Wolf E. Insulin-like growth factor binding protein 2 (IGFBP-2) separates hypertrophic and hyperplastic effects of growth hormone (GH)/IGF-I excess on adrenocortical cells in vivo. FASEB J 16:1721-1731, 2002.
8. Coulter CL, Goldsmith PC, Mesiano S, Voytek CC, Martin MC, Han VK, Jaffe RB. Functional maturation of the primate fetal adrenal in vivo: I. Role of insulin-like growth factors (IGFs), IGF-I receptor, and IGF binding proteins in growth regulation. Endocrinology 137:4487-4498, 1996.
9. Agha A, Monson JP. Modulation of glucocorticoid metabolism by the growth hormone-IGF-1 axis. Clin Endocrinol (Oxf) 66:459-465, 2007.
10. Williams GH. Aldosterone biosynthesis, regulation, and classical mechanism of action. Heart Fail Rev 10:7-13, 2005.
11. Seely EW, Conlin PR, Brent GA, Dluhy RG. Adrenocorticotropin stimulation of aldosterone: Prolonged continuous versus pulsatile infusion. J Clin Endocrinol Metab 69:1028-1032, 1989.
12. Williams GH. Cardiovascular benefits of aldosterone receptor antagonists: What about potassium? Hypertension 46:265-266, 2005.
13. Manolopoulou J, Bielohuby M, Caton SJ, Gomez-Sanchez CE, Renner-Mueller I, Wolf E, Lichtenauer UD, Beuschlein F, Hoeflich A, Bidlingmaier M. A highly sensitive immunofluorometric assay for the measurement of aldosterone in small sample volumes: Validation in mouse serum. J Endocrinol 196:215-224, 2008.
14. Vasan RS, Evans JC, Larson MG, Wilson PW, Meigs JB, Rifai N, Benjamin EJ, Levy D. Serum aldosterone and the incidence of hypertension in nonhypertensive persons. N Engl J Med 351:33-41, 2004.
15. Melmed S. Acromegaly. N Engl J Med 322:966-977, 1990.
16. Lombardi G, Galdiero M, Auriemma RS, Pivonello R, Colao A. Acromegaly and the cardiovascular system. Neuroendocrinology 83:211-217, 2006.
17. Colao A, Ferone D, Marzullo P, Lombardi G. Systemic complications of acromegaly: Epidemiology, pathogenesis, and management. Endocr Rev 25:102-152, 2004.
18. Strauch G, Vallotton MB, Touitou Y, Bricaire H. The renin-angiotensin- aldosterone system in normotensive and hypertensive patients with acromegaly. N Engl J Med 287:795-799, 1972.
19. Lim NY, Dingman JF. Androgenic adrenal hyperfunction in acromegaly. N Engl J Med 271:1189-1194, 1964.
20. Nicklas W, Baneux P, Boot R, Decelle T, Deeny AA, Fumanelli M, Illgen-Wilcke B. Recommendations for the health monitoring of rodent and rabbit colonies in breeding and experimental units. Lab Anim 36:20-42, 2002.
21. Hoeflich A, Wu M, Mohan S, Foll J, Wanke R, Froehlich T, Arnold GJ, Lahm H, Kolb HJ, Wolf E. Overexpression of insulin-like growth factor-binding protein-2 in transgenic mice reduces postnatal body weight gain. Endocrinology 140:5488-5496, 1999.
22. Hoeflich A, Nedbal S, Blum WF, Erhard M, Lahm H, Brem G, Kolb HJ, Wanke R, Wolf E. Growth inhibition in giant growth hormone transgenic mice by overexpression of insulin-like growth factor-binding protein-2. Endocrinology 142:1889-1898, 2001.
23. Elmlinger MW, Kuhnel W, Weber MM, Ranke MB. Reference ranges for two automated chemiluminescent assays for serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 (IGFBP-3). Clin Chem Lab Med 42:654-664, 2004.
24. Castrop H, Lorenz JN, Hansen PB, Friis U, Mizel D, Oppermann M, Jensen BL, Briggs J, Skott O, Schnermann J. Contribution of the basolateral isoform of the Na-K-2Cl- cotransporter (NKCC1/BSC2) to renin secretion. Am J Physiol Renal Physiol 289:F1185-F1192, 2005.
25. Moller J, Jensen MB, Frandsen E, Moller N, Kissmeyer P, Laurberg S. Growth hormone treatment improves body fluid distribution in patients undergoing elective abdominal surgery. Clin Endocrinol (Oxf) 49:597-602, 1998.
26. Hoffman DM, Crampton L, Sernia C, Nguyen TV, Ho KK. Short-term growth hormone (GH) treatment of GH-deficient adults increases body sodium and extracellular water, but not blood pressure. J Clin Endocrinol Metab 81:1123-1128, 1996.
27. Ekman B, Ohman PK, Arnqvist HJ, Lindstrom T, Nystrom FH. Individualized growth hormone substitution with normalized IGF-I levels does not stimulate the renin-angiotensin-aldosterone system. Clin Endocrinol (Oxf) 57:473-479, 2002.
28. Lampit M, Nave T, Hochberg Z. Water and sodium retention during short-term administration of growth hormone to short normal children. Horm Res 50:83-88, 1998.
29. Ho KY, Weissberger AJ. The antinatriuretic action of biosynthetic human growth hormone in man involves activation of the reninangiotensin system. Metabolism 39:133-137, 1990.
30. Hansen TK, Moller J, Thomsen K, Frandsen E, Dall R, Jorgensen JO, Christiansen JS. Effects of growth hormone on renal tubular handling of sodium in healthy humans. Am J Physiol Endocrinol Metab 281:E1326-E1332, 2001.
31. Hanukoglu A, Belutserkovsky O, Phillip M, Growth hormone activates renin-aldosterone system in children with idiopathic short stature and in a pseudohypoaldosteronism patient with a mutation in epithelial sodium channel alpha subunit. J Steroid Biochem Mol Biol 77:49-57, 2001.
32. Weaver JU, Thaventhiran L, Noonan K, Burrin JM, Taylor NF, Norman MR, Monson JP. The effect of growth hormone replacement on cortisol metabolism and glucocorticoid sensitivity in hypopituitary adults. Clin Endocrinol (Oxf) 41:639-648, 1994.
33. Bondanelli M, Ambrosio MR, degli Uberti EC. Pathogenesis and prevalence of hypertension in acromegaly. Pituitary 4:239-249, 2001.
34. Jaffrain-Rea ML, Minniti G, Moroni C, Esposito V, Ferretti E, Santoro A, Infusino T, Tamburrano G, Cantore G, Cassone R. Impact of successful transsphenoidal surgery on cardiovascular risk factors in acromegaly. Eur J Endocrinol 148:193-201, 2003.
35. Colao A, Terzolo M, Bondanelli M, Galderisi M, Vitale G, Reimondo G, Ambrosio MR, Pivonello R, Lombardi G, Angeli A, Degli Uberti EC. GH and IGF-I excess control contributes to blood pressure control: Results of an observational, retrospective, multicentre study in 105 hypertensive acromegalic patients on hypertensive treatment. Clin Endocrinol (Oxf), 2008.
36. Wyse B, Waters M, Sernia C. Stimulation of the renin-angiotensin system by growth hormone in Lewis dwarf rats. Am J Physiol 265(2 Pt 1):E332-E339, 1993.
37. Wolf E, Lahm H, Wu M, Wanke R, Hoeflich A. Effects of IGFBP-2 overexpression in vitro and in vivo. Pediatr Nephrol 14:572-578, 2000.
38. Wolf E, Jehle PM, Weber MM, Sauerwein H, Daxenberger A, Breier BH, Besenfelder U, Frenyo L, Brem G. Human insulin-like growth factor I (IGF-I) produced in the mammary glands of transgenic rabbits: Yield, receptor binding, mitogenic activity, and effects on IGF-binding proteins. Endocrinology 138:307-313, 1997.
39. Fisch T. Effects of insulin-like growth factor binding protein-2 (IGFBP-2) overexpression on adrenal and renal growth processes and functions: Findings in transgenic mouse models. Doctoral thesis, Institute of Veterinary Pathology. Ludwig-Maximilians University, Munich, 2004.
40. Bohlooly YM, Carlson L, Olsson B, Gustafsson H, Andersson IJ, Tornell J, Bergstrom G. Vascular function and blood pressure in GH transgenic mice. Endocrinology 142:3317-3323, 2001.
41. Kamenicky P, Viengchareun S, Blanchard A, Meduri G, Zizzari P, Imbert-Teboul M, Doucet A, Chanson P, Lombes M. Epithelial sodium channel is a key mediator of growth hormone-induced sodium retention in acromegaly. Endocrinology 149:3294-3305, 2008.
42. Mulatero P, Veglio F, Maffei P, Bondanelli M, Bovio S, Daffara F, Leotta G, Angeli A, Calvo C, Martini C, Degli Uberti EC, Terzolo M. CYP11B2-344T/C gene polymorphism and blood pressure in patients with acromegaly. J Clin Endocrinol Metab 91:5008-5012, 2006.
43. Spyroglou A, Manolopoulou J, Wagner S, Bidlingmaier M, Reincke M, Beuschlein F. Short term regulation of aldosterone secretion after stimulation and suppression experiments in mice. J Mol Endocrinol, 2009.
44. Davies E, MacKenzie SM. Extra-adrenal production of corticosteroids. Clin Exp Pharmacol Physiol 30:437-445, 2003.
45. Ye P, Kenyon CJ, Mackenzie SM, Nichol K, Seckl JR, Fraser R, Connell JM, Davies E. Effects of ACTH, dexamethasone, and adrenalectomy on 11beta-hydroxylase (CYP11B1) and aldosterone synthase (CYP11B2) gene expression in the rat central nervous system. J Endocrinol 196:305-311, 2008.